Among patients with PL, 61% were responders regarding glucose homeostasis, and 61% were responders regarding hypertriglyceridemia at year 1, with those with more severe metabolic disease and lower leptin at baseline, as well as those with preserved β-cell functions, likely being better responders. This evidence concerns the gene LEP and hypertriglyceridemia.